Chiesi Group

Certified B Corporation

Emilia-Romagna, Italy

Certified Since

May 2019


Pharmaceutical products



Operates In














Netherlands The,

New Zealand,











United Kingdom,

United States

Chiesi Group is an international research-focused pharmaceuticals and healthcare group with over 85 years’ experience with more than 6,000 employees worldwide and a commercial presence in 100 countries. To achieve its mission of improving people’s quality of life by acting responsibly towards society and the environment, the Group researches, develops and markets innovative therapeutic solutions in three focus areas: AIR (products and services that promote respiration, from new-born to adult populations), RARE (treatment for patients with rare and ultra-rare diseases) and CARE (products and services that support specialty care and consumer-facing self-care). Chiesi Group has direct Affiliates in 30 countries worldwide plus 68 countries where Chiesi is present with a network of partners. Chiesi became a certified B Corp in 2019 and a Benefit Corporation, thus choosing to adopt a new legal status under Italian, US and French law. With the B Corp Certification, Chiesi reinforces its mission to improve the quality of human life, by acting responsibly towards the society and the environment and by adopting a unified standard of measurement within the Group.

Overall B Impact Score

Based on the B Impact assessment, Chiesi Group earned an overall score of 103.7. The median score for ordinary businesses who complete the assessment is currently 50.9.
103.7 Overall B Impact Score
80 Qualifies for B Corp Certification
50.9 Median Score for Ordinary Businesses

Governance 17.1

Governance evaluates a company's overall mission, engagement around its social/environmental impact, ethics, and transparency. This section also evaluates the ability of a company to protect their mission and formally consider stakeholders in decision making through their corporate structure (e.g. benefit corporation) or corporate governing documents.

Workers 26.7

Workers evaluates a company’s contributions to its employees’ financial security, health & safety, wellness, career development, and engagement & satisfaction. In addition, this section recognizes business models designed to benefit workers, such as companies that are at least 40% owned by non-executive employees and those that have workforce development programs to support individuals with barriers to employment.

Community 17.5

Community evaluates a company’s engagement with and impact on the communities in which it operates, hires from, and sources from. Topics include diversity, equity & inclusion, economic impact, civic engagement, charitable giving, and supply chain management. In addition, this section recognizes business models that are designed to address specific community-oriented problems, such as poverty alleviation through fair trade sourcing or distribution via microenterprises, producer cooperative models, locally focused economic development, and formal charitable giving commitments.

Environment 16.8

Environment evaluates a company’s overall environmental management practices as well as its impact on the air, climate, water, land, and biodiversity. This includes the direct impact of a company’s operations and, when applicable its supply chain and distribution channels. This section also recognizes companies with environmentally innovative production processes and those that sell products or services that have a positive environmental impact. Some examples might include products and services that create renewable energy, reduce consumption or waste, conserve land or wildlife, provide less toxic alternatives to the market, or educate people about environmental problems.

Customers 25.5

Customers evaluates a company’s stewardship of its customers through the quality of its products and services, ethical marketing, data privacy and security, and feedback channels. In addition, this section recognizes products or services that are designed to address a particular social problem for or through its customers, such as health or educational products, arts & media products, serving underserved customers/clients, and services that improve the social impact of other businesses or organizations.

Previous Overall B Impact Scores

2022 Overall B Impact Score103.7
2019 Overall B Impact Score87.5

Additional Documentation

Chiesi Group Score Methodology Summary

Chiesi Group Pharmaceutical Industry Statement 2022

Chiesi Animal Testing Disclosure 2022

Chiesi Group Disclosure Report 2022

Chiesi Score Aggregation Methodology 2022

Chiesi Disclosures 2019

B Labs Logo - Home Link

Sign up to our Insights newsletter, a monthly digest of the latest news on economic systems change from B Lab Global.

We take the security of your data seriously, read our privacy policy for further information. For newsletter communications relating to your local region, please visit Global Partner sites to subscribe.

Copyright © 2024 B Lab. All rights reserved.